Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02410980 · ClinicalTrials.gov registry record · Early Phase 1

Assessing the Effects of Tretinoin Cream on Human Skin With Optical Imaging Technologies

A Early Phase 1 study of Collagen Fibril Alteration, sponsored by University of California, Irvine.

Completed
Registry status
Early Phase 1
Development phase
15
Enrollment target
1
Study location

NCT02410980: Completed Early Phase 1 study of Collagen Fibril Alteration, sponsored by University of California, Irvine.

NCT02410980 is a Early Phase 1 study of Collagen Fibril Alteration that has completed, run by University of California, Irvine. The registered enrollment target is 15 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02410980, a Early Phase 1 study of Collagen Fibril Alteration, has completed, sponsored by University of California, Irvine.

COMPLETED
Registry status
Early Phase 1
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

The researchers will assess the effects of treatment with tretinoin cream on human skin by using non-invasive optical imaging technologies.

Primary Outcome

The effects of tretinoin cream on human skin will be measured.

Conditions Studied

Interventions

  • DRUG Tretinoin cream 0.1%

Study Locations (1)

California

  • Beckman Laser Institute Medical Clinic - Irvine

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2015-08
Est. Completion 2016-12
Phase Early Phase 1
University of California, Irvine

368 total trials

What the finished NCT02410980 record still lists

NCT02410980 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (72% lower).

The record links to 1 condition, with Collagen Fibril Alteration appearing as the primary indexed condition, and to 1 intervention - of which Tretinoin cream 0.1% is the first listed.

NCT02410980 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT02410980 about?

NCT02410980 is a clinical study titled "Assessing the Effects of Tretinoin Cream on Human Skin With Optical Imaging Technologies". The researchers will assess the effects of treatment with tretinoin cream on human skin by using non-invasive optical imaging technologies.

What is the current status of trial NCT02410980?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 15 participants. The study started on 2015-08. Estimated completion is 2016-12.

What conditions does trial NCT02410980 study?

This clinical trial studies the following conditions: Collagen Fibril Alteration.

What interventions are being tested in trial NCT02410980?

The interventions under investigation include: Tretinoin cream 0.1% (DRUG).

Who is sponsoring clinical trial NCT02410980?

This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02410980 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT02410980's enrollment target sits among peer trials

15 1404th of 2000 higher than 527 of 2,000 other Early Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02410980, the US trial registry maintained by the National Library of Medicine. NCT02410980 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.